Medicina
Department
Hospital Universitario Lucus Augusti
Lugo, EspañaPublications in collaboration with researchers from Hospital Universitario Lucus Augusti (26)
2024
-
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Annals of Hematology, Vol. 103, Núm. 8, pp. 2845-2851
-
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
Cancer, Vol. 130, Núm. 20, pp. 3436-3451
-
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study
Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
-
Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)
Revista Espanola de Cardiologia
2023
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
-
Cognitive impairment and dementia in young onset Parkinson’s disease
Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812
-
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
Blood Cancer Journal, Vol. 13, Núm. 1
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
2022
-
A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial
BMC medicine, Vol. 20, Núm. 1, pp. 83
-
Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry
Leukemia Research, Vol. 115
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
Blood Advances, Vol. 6, Núm. 4, pp. 1278-1295
2021
-
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
Leukemia, Vol. 35, Núm. 6, pp. 1571-1585
-
Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
PLoS ONE, Vol. 16, Núm. 2 February
-
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
BMC Neurology, Vol. 21, Núm. 1
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia
2020
-
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
-
Study of the Diagnostic Delay of Tuberculosis in Spain
Archivos de Bronconeumologia